Cite
APA Citation
Hurwitz, H., Zafar, Y., Kozloff, M., Hubbard, J., Van Cutsem, E., Bennouna, J., Arnold, D., Bekaii-Saab, T., Srock, S., Revil, C., Fish, S., Barue, V., & Grothey, A. (n.d.). 2141 Safety outcomes from 3 observational or phase 4 studies of bevacizumab (Bev) in metastatic colorectal cancer (mCRC). European journal of cancer, 51, S379–S380. http://access.bl.uk/ark:/81055/vdc_100030628213.0x00002e